Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma

被引:1
|
作者
Liu, Baiyi [1 ]
Wang, Xiaoxiao [1 ]
Wu, Nan [1 ]
Liu, Feng [1 ]
Rao, Huiying [1 ]
机构
[1] Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing Int Cooperat Base Sci & Technol NAFLD Diag, Beijing, Peoples R China
关键词
Nonalcoholic fatty liver disease (NAFLD); hepatocellular carcinoma (HCC); biomarkers; progression; prognosis; FIBROSIS STAGE; INFLAMMATION; VERSICAN; CELLS; NASH; STEATOHEPATITIS; PREVALENCE; PLATELETS; APOPTOSIS; PROTEIN;
D O I
10.2174/0109298673288887240212065116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. With an increasing number of patients, NAFLD has been identified as a risk factor for Hepatocellular Carcinoma (HCC). The precise pathophysiology of NAFLD-related HCC has not been completely understood recently.Objective We analyzed the hub genes related to NAFLD and HCC to predict the risk of NAFLD progressing to HCC.Methods Two datasets of NAFLD were used to identify differentially expressed genes. Lasso-Cox regression analysis was performed to determine a gene model to predict the risk of the progression from NAFLD to HCC. Three validation datasets were analyzed to evaluate the performance of the gene model, including normal and NAFLD with fibrosis, NAFLD with fibrosis and NAFLD-related HCC, and normal and NASH-related HCC.Results Seven genes, including COL1A1, TIPM1, VCAN, FOS, CD79A, CXCL9, and VWF, were identified as the hub genes, and then a gene model was constructed. By calculating, the area under the receiver operating characteristic curves (AUCs) for risk prediction were 0.97, 0.886, and 0.751 in the three validation datasets, respectively. Gene set enrichment analysis indicated that the MAPK, TGF beta, p53, PPAR, insulin signaling pathways, and fatty acid metabolism were significantly upregulated in the high-risk group. GTPase activity and intrinsic apoptotic signaling pathway had significant upregulation in the low-risk group.Conclusion The seven hub genes may predict the risk of NAFLD developing into HCC by mediating the potential molecular mechanism, which could be used as biomarkers for predicting the progression, diagnosis, and treatment of NAFLD.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
    ?ngelo Z Mattos
    Jose D Debes
    Renu Dhanasekaran
    Jihane N Benhammou
    Marco Arrese
    André Luiz V Patrício
    Amanda C Zilio
    Angelo A Mattos
    World Journal of Hepatology, 2021, 13 (09) : 1107 - 1121
  • [22] Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Wakai, Toshifumi
    Shirai, Yoshio
    Sakata, Jun
    Korita, Pavel Vladimirovich
    Ajioka, Yoichi
    Hatakeyama, Katsuyoshi
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (08) : 1450 - 1458
  • [23] Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
    Mattos, Angelo Z.
    Debes, Jose D.
    Dhanasekaran, Renu
    Benhammou, Jihane N.
    Arrese, Marco
    Patricio, Andre Luiz, V
    Zilio, Amanda C.
    Mattos, Angelo A.
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (09) : 1107 - 1121
  • [24] Expected increase of hepatocellular carcinoma by nonalcoholic fatty liver disease
    Alt, Y.
    Schattenberg, J. M.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (04): : 364 - 365
  • [25] Predictors of hepatocellular carcinoma development in nonalcoholic fatty liver disease
    Yuan, Jian-Min
    Wang, Renwei
    Luu, Hung N.
    Behari, Jaideep
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
    Starley, Brad Q.
    Calcagno, Christopher J.
    Harrison, Stephen A.
    HEPATOLOGY, 2010, 51 (05) : 1820 - 1832
  • [27] Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease
    Wu, Chutian
    Zhou, Yun
    Wang, Min
    Dai, Guolin
    Liu, Xiongxiu
    Lai, Leizhen
    Tang, Shaohui
    FRONTIERS IN GENETICS, 2021, 12
  • [28] Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
    Koh, Ye Xin
    Tan, Hiang Jin
    Liew, Yi Xin
    Syn, Nicholas
    Teo, Jin Yao
    Lee, Ser Yee
    Goh, Brian K. P.
    Goh, George B. B.
    Chan, Chung Yip
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (05) : 467 - +
  • [29] Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma
    Jun Han
    Wen-Tao Yan
    Bing Quan
    Ming-Da Wang
    Tian Yang
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (02) : 202 - 202
  • [30] EFFECTS OF SCREENING IN NONALCOHOLIC FATTY LIVER DISEASE AND CRYPTOGENIC HEPATOCELLULAR CARCINOMA
    Chen, Vincent L.
    Yeh, Ming-Lun
    Yang, Ju Dong
    Prasad, Debi
    Guy, Jennifer
    Saeed, Waqar K.
    Jun, Tomi
    Tsai, Pei-Chien
    Nguyen, Pauline
    Huang, Chung-Feng
    Lee, Hyo Young
    Giama, Nasra H.
    Kim, Nathan G.
    Le, An K.
    Dang, Hansen
    Ali, Hamdi A.
    Zhang, Ning
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Huang, Yi-Hsiang
    Jun, Dae Won
    Gane, Edward
    Roberts, Lewis R.
    Yu, Ming-Lun
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2018, 154 (06) : S1238 - S1238